Collaborative facilities, Service platforms
The Genopole® biopark features 18 shared-use facilities and infrastructure - most of which are open to the biopark’s scientific and business communities.
This infrastructure has been established thanks to steadfast financial support from Genopole®’s usual partners (the Ministry for Higher Education and Research, Ile-de-France Regional Council, Essonne County Council, the Regional Directorate for Industry, Research and the Environment (DRIRE), the Essonne Chamber of Commerce and Industry, the French Muscular Dystrophy Association, the University of Evry-Val d’Essonne, the CEA, the INSERM and the CNRS), as well as additional contributions from the Ecole Nationale Supérieure des Mines de Paris, Armines and the Paris VI and Paris XIII universities.
The Genopole® Infrastructure team is committed to responding to requests for new facilities and promoting the development, accreditation and operation of existing ones.
18 shared-use facilities :
A technology platform is defined here as the assembly of equipment and human resources in a single location, with a view to offering the user community access to high-level technological resources.
14 shared-use technology platforms:
- The abSYTNH Facility
- Cell Sorting Workstation
- Evr@ Platform : Virtual Environment and @ugmented Reality
- HTS Platform
- Structural Biology Platform
- Transcriptomics Platform
- Center for Exploration and Experimental Functional Research - CERFE
- DNA and Cell Bank
- Experimental Irradiator
- Center for functional Investigation and Experimental Research in Amphibians and Fish - CERFAP
- Imaging and Cytometry Platform
- Mass Spectrometry Platform
- MicroScope Platform
- Transmission Electron Microscopy
- Genopole Biomanufacturing Center
1 shared-use technical facility:
2 other infrastructure:
Three of these platforms have been awarded IBiSA accreditation* (*) by the French government:
- Transcriptomics platform
- The Genoscope MicroScope platform
- The Genethon DNA and Cell Library
(*)IBiSA accreditation (“Infrastructure in healthcare, biology and agronomy”) replaced the French government’s RIO accreditation in 2007.
Under the terms of the IBiSA charter, the operator of the platform (defined as the assembly of equipment and human resources in a single location, with a view to offering the user community access to high-level technological resources) undertakes to provide access not only to on-site users but also to those based regionally and nationally, regardless of their status (publicly-funded labs, companies, etc.).
Platform accreditation and the specific resources (funding, staff) which are attributed accordingly are conditional on provision of a general specification and, depending on the platform’s theme, a more detailed specification. Each platform has a Scientific Advisory Board (comprising both users and external experts) that defines project priorities, ensures the quality of the services offered and suggests methodological changes and upgrades. The platform must display a formal service offering which specifies the access conditions and tariffs.
The platform must set up a quality management system based on the ISO 9001 v2000 standard. It must ensure its long-term technological performance level by performing methodological research that leads to scientific publications or research exploitation.
Regular support for the acquisition of semi-heavy equipment :
Each year, Genopole® launches a call for tenders for the acquisition of semi-heavy equipment which can help provide optimal working conditions for existing research groups or attract and anchor new ones. In parallel, Genopole® assists with the acquisition of additional equipment when justified by the development of new themes, the arrival of new researchers, students and trainees and the establishment of new collaborations.
This operation complements the funding provided by the national research institutes when the latter establish and develop research units on the Evry biopark. In line with the spirit of resource-sharing that prevails at Genopole®, the items of equipment are distributed to and operated by the various research groups but can be accessed by all members of the campus scientific and business communities.
To find out more, consult the online directory of the shared-use facilities.
« Au service des entreprises dédiées à l’innovation thérapeutique, Acriter a fait le choix en 2004 de (...)
« Genopole® a tout simplement permis d’accomplir mon rêve de chercheur : créer un laboratoire capable de (...)
« A Genopole®, j’ai trouvé un grand professionnalisme dans l’accueil et le suivi des entreprises. Le (...)